Loring Wolcott & Coolidge Fiduciary Advisors’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.44K | Hold |
460
| – | – | ﹤0.01% | 524 |
|
|
2026
Q1 | $10.4K | Hold |
460
| – | – | ﹤0.01% | 515 |
|
|
2025
Q4 | $7.19K | Hold |
460
| – | – | ﹤0.01% | 505 |
|
|
2025
Q3 | $6.38K | Hold |
460
| – | – | ﹤0.01% | 508 |
|
|
2025
Q2 | $5.27K | Hold |
460
| – | – | ﹤0.01% | 496 |
|
|
2025
Q1 | $5.44K | Hold |
460
| – | – | ﹤0.01% | 503 |
|
|
2024
Q4 | $8.79K | Hold |
460
| – | – | ﹤0.01% | 491 |
|
|
2024
Q3 | $8.56K | Sell |
460
-2,912
| -86% | -$59.5K | ﹤0.01% | 504 |
|
|
2024
Q2 | $84.3K | Sell |
3,372
-4,175
| -55% | -$109K | ﹤0.01% | 350 |
|
|
2024
Q1 | $199K | Sell |
7,547
-615
| -8% | -$17.5K | ﹤0.01% | 274 |
|
|
2023
Q4 | $246K | Sell |
8,162
-460
| -5% | -$12.5K | ﹤0.01% | 260 |
|
|
2023
Q3 | $211K | Sell |
8,622
-1,041
| -11% | -$35.7K | ﹤0.01% | 281 |
|
|
2023
Q2 | $356K | Sell |
9,663
-350
| -3% | -$10.7K | ﹤0.01% | 236 |
|
|
2023
Q1 | $300K | Sell |
10,013
-2,307
| -19% | -$76K | ﹤0.01% | 239 |
|
|
2022
Q4 | $377K | Sell |
12,320
-49
| -0.4% | -$1.47K | ﹤0.01% | 225 |
|
|
2022
Q3 | $305K | Buy |
12,369
+325
| +3% | +$10.7K | ﹤0.01% | 246 |
|
|
2022
Q2 | $386K | Hold |
12,044
| – | – | ﹤0.01% | 227 |
|
|
2022
Q1 | $379K | Hold |
12,044
| – | – | ﹤0.01% | 234 |
|
|
2021
Q4 | $404K | Buy |
12,044
+9,307
| +340% | +$290K | ﹤0.01% | 234 |
|
|
2021
Q3 | $80K | Buy |
2,737
+50
| +2% | +$1.62K | ﹤0.01% | 412 |
|
|
2021
Q2 | $94K | Buy |
+2,687
| New | +$89K | ﹤0.01% | 406 |
|
|
2021
Q1 | – | Sell |
-5,036
| Closed | -$125K | – | 374 |
|
|
2020
Q4 | $125K | Hold |
5,036
| – | – | ﹤0.01% | 323 |
|
|
2020
Q3 | $105K | Hold |
5,036
| – | – | ﹤0.01% | 316 |
|
|
2020
Q2 | $77K | Hold |
5,036
| – | – | ﹤0.01% | 336 |
|
|
2020
Q1 | $45K | Sell |
5,036
-40
| -0.8% | -$577 | ﹤0.01% | 389 |
|
|
2019
Q4 | $92K | Hold |
5,076
| – | – | ﹤0.01% | 355 |
|
|
2019
Q3 | $76K | Hold |
5,076
| – | – | ﹤0.01% | 368 |
|
|
2019
Q2 | $122K | Hold |
5,076
| – | – | ﹤0.01% | 317 |
|
|
2019
Q1 | $189K | Hold |
5,076
| – | – | ﹤0.01% | 262 |
|
|
2018
Q4 | $143K | Sell |
5,076
-100
| -2% | -$3.16K | ﹤0.01% | 282 |
|
|
2018
Q3 | $204K | Sell |
5,176
-123
| -2% | -$5.38K | ﹤0.01% | 268 |
|
|
2018
Q2 | $235K | Hold |
5,299
| – | – | ﹤0.01% | 260 |
|
|
2018
Q1 | $258K | Sell |
5,299
-30
| -0.6% | -$1.5K | ﹤0.01% | 250 |
|
|
2017
Q4 | $267K | Hold |
5,329
| – | – | ﹤0.01% | 249 |
|
|
2017
Q3 | $270K | Sell |
5,329
-648
| -11% | -$30.6K | 0.01% | 250 |
|
|
2017
Q2 | $285K | Sell |
5,977
-75
| -1% | -$2.96K | 0.01% | 241 |
|
|
2017
Q1 | $233K | Sell |
6,052
-1,920
| -24% | -$57.8K | ﹤0.01% | 258 |
|
|
2016
Q4 | $176K | Sell |
7,972
-15
| -0.2% | -$308 | ﹤0.01% | 279 |
|
|
2016
Q3 | $128K | Hold |
7,987
| – | – | ﹤0.01% | 311 |
|
|
2016
Q2 | $66K | Buy |
7,987
+546
| +7% | +$4.87K | ﹤0.01% | 370 |
|
|
2016
Q1 | $52K | Sell |
7,441
-1,007
| -12% | -$5.06K | ﹤0.01% | 386 |
|
|
2015
Q4 | $45K | Buy |
+8,448
| New | +$54K | ﹤0.01% | 429 |
|
Other funds holding CC
CCPM
Loring Wolcott & Coolidge Fiduciary Advisors's CC Position: Q2 2026 in Review
Loring Wolcott & Coolidge Fiduciary Advisors held its Chemours (CC) position steady in Q2 2026 at 460 shares worth $9.44K. The position accounts for ﹤0.01% of the portfolio, ranked #524.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in CC in Q4 2015 and has held it in 42 quarters since. The position peaked at $404K in Q4 2021. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors held 460 shares of Chemours worth $9.44K as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors left its Chemours share count unchanged in Q2 2026.
- Chemours made up ﹤0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #524 holding.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Chemours in Q4 2015 and has held it in 42 quarters since.
- Loring Wolcott & Coolidge Fiduciary Advisors's Chemours position peaked at $404K in Q4 2021.
- 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.